Treatment of intraoperative hypertensive emergencies in patients with intracranial disease

Aken, Hugo Van; Cottrell, James E.; Anger, C.; Puchstein, Christoph

doi:10.1016/0002-9149(89)90406-2

Cited by 19 publications

(3 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The use of alpha-and beta-adrenergic receptor antagonists has been advocated in such patients [83]. The combined alpha-and beta-adrenoceptor antagonist, labetalol, has been compared with esmolol to treat patients after craniotomy who exhibited significant hypertension after tracheal extubation [59].…”

Section: Preventionmentioning

confidence: 99%

Problems Associated With Tracheal Extubation

Hartley

Vaughan

1993

British Journal of Anaesthesia

184

113

View full text Add to dashboard Cite

Section: Preventionmentioning

confidence: 99%

Problems Associated With Tracheal Extubation

Hartley

Vaughan

1993

British Journal of Anaesthesia

184

113

View full text Add to dashboard Cite

“…Full maintenance of sodium should be given as hyponatraemia impairs cerebrovascular reactivity and serum sodium level should be maintained above 140mmol/l. Hypo/Hypertension (138)(139)(140)(141)(142)(143)(144)(145)(146)(147)(148)(149) For ensuring adequate organ perfusion, monitoring and maintenance of arterial blood pressure and blood volume in normal limits are essential. Arterial catheterization is indicated in ICU setting when abnormal blood pressure threatens to compromise blood flow to the brain, exacerbate high intracranial pressure.…”

Section: Hypovolaemiamentioning

confidence: 99%

Emergency Medicine - An International Perspective

Blaivas¹

2012

View full text Add to dashboard Cite

users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. After this work has been published by InTech, authors have the right to republish it, in whole or part, in any publication of which they are the author, and to make other personal use of the work. Any republication, referencing or personal use of the work must explicitly identify the original source. As for readers, this license allows users to download, copy and build upon published chapters even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. Notice Statements and opinions expressed in the chapters are these of the individual contributors and not necessarily those of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the use of any materials, instructions, methods or ideas contained in the book.

show abstract

“…If treatment of systemic pressure is needed, a short-acting beta-adrenergic receptor antagonist would be preferred over a more potent vasodilator (i.e. hydralazine or nitroprusside) that may increase cerebral blood flow and intracranial pressure or result in systemic hypotension [119].…”

Section: Increase Intracranial Pressurementioning

confidence: 99%